For Authors

Only those that significantly contributed to the work should be listed as authors. Individuals who provided minor assistance or advice on the research or manuscript should be listed in the Acknowledgment section of the manuscript. Authors should not include the journal editors or reviewers in the acknowledgment section of the manuscript, rather in the response letter. Authors are encouraged to keep the “co-first authorship” to only two authors, with only one corresponding author.

Types of Publications GGPGR restricts Original Articles to 10,000 words, Reviews to 12,000 and Case Reports to 5,000. All word counts exclude title page, abstract, acknowledgements, references, figure legends, and tables. There are no restrictions on the number of figures and/or tables included in the main text, however, each figure cannot contain more than eight panels (A–G). References should be limited to 60 for Original Articles, 100 for Reviews, and 40 for Case Reports. Full experimental details must be provided so that the results can be reproduced. GGPGR requires that authors publish all experimental controls and make full datasets available for review where possible.

Manuscripts submitted to GGPR should neither be published previously nor be under consideration for publication in another journal. The main article types are as follows:

• Original Articles: Original research manuscripts. The journal considers all original research manuscripts provided that the work reports scientifically sound experiments and provides a substantial amount of new information. The quality and impact of the study will be considered during peer review.
• Reviews: These provide concise and precise updates on the latest progress made in a given area of research. Systematic reviews should follow the PRISMA guidelines.
• Case Reports: These present detailed information on the symptoms, signs, diagnosis, treatment (including all types of interventions), and outcomes of an individual patient. Case reports usually describe new or uncommon conditions that serve to enhance medical care or highlight diagnostic approaches.

Your manuscript your way

For the initial submission, authors are welcome to submit their manuscript in any format without having to comply with the formatting guidelines of GGPR. Figures and tables must however be inserted in the manuscript and submitted as one PDF file. References can be in any format as long as they are consistent. Upon acceptance, authors are asked to format the manuscript in accordance with GGPR using the Microsoft Word template.

Authors are encouraged to use the Microsoft Word template to prepare their manuscript. Using the template file will substantially shorten the time to complete copy-editing and publication of accepted manuscripts. The total amount of data for all files must not exceed 120 MB. Should you face any difficulty during the submission process or if the files are larger than 120 MB, please contact the Editorial Office at support@ggpgr.com.

Accepted file formats are:

• Microsoft Word: Manuscripts prepared in Microsoft Word must be converted into a single file before submission. Please insert your graphics (schemes, figures, tables, etc.) in the main text after the paragraph of its first citation
• Supplementary files: Supplementary files should be submitted using the Supplementary File Word template
• GGPR does not accept LaTeX manuscripts.

GGPGR does not require, nor accept, the inclusion of cover letters with manuscript submissions. All necessary information should be provided directly on the submission portal.

• Language: Manuscripts must be prepared according to American English language standards. Authors whose first language is not English must have their manuscript edited by an English native speaker or an English language editing service. All abbreviations must be first defined upon first mentioned.
• Research manuscripts should comprise:
  • Title Page:Title, Author list, Affiliations, Highlights, Abstract, Keywords
  • Main Body: Introduction, Materials and Methods, Results, Discussion, Conclusions.
  • Declarations and References: Acknowledgments, Author Contributions, Conflicts of Interest, References.
  • Figures and tables, along with their legends, are to be embedded in the manuscript where they are first mentioned.
• Reviews should comprise Introduction, literature review sections, and Discussion. It is not necessary to follow the remaining structure in the manuscript template; authors are expected to restructure the template accordingly while retaining the font, references style, margins, and Figures and tables guidelines.
• Case reports should include a brief introduction, the case presentation with a description of the symptoms, diagnosis, treatment, and outcome; a discussion of the context and treatment decisions; a conclusion. The name of the institution(s) where consultations and treatments took place must also be included. No subject names should be mentioned in the manuscript.
• Graphical Abstract (Optional):Authors are encouraged to submit a graphical abstract that represents the topic of the article in an attention-grabbing way. The Graphical abstract must be original and unpublished artwork and lack any trademarked item.
• Acronyms/Abbreviations/Initialisms should be defined the first time they appear in each of three sections: the abstract; the main text; figures and tables legends. When defined for the first time, the acronym/abbreviation/initialism should be added in parentheses after the written-out form. Common terms like RNA and DNA can be used without prior write-out.
• SI Units (International System of Units) should be used. For hour, minute, and second, used h, min, and s, respectively. Days, weeks, and years should not be abbreviated. “L” should be used for liters while mol/L should be used for concentration. When expressing time, use the military time system; for example, for 1 pm, use 13:00. To indicate sex, males and females must be used.
• Accession numbers of RNA, DNA and protein sequences used in the manuscript should be provided in the Materials and Methods section or as a Supplementary Table.
• Equations:Use either the Microsoft Equation Editor or the MathType add-on. Equations should be editable and not appear as a picture.
• Research Data: Publication of manuscripts implies that you must make all materials, data, and protocols associated with the publication available to readers. During the review process, authors may be requested to provide the original data for review.

Title Page

• Title: Authors should select a concise and attractive title. Do not include abbreviations in the title. Provide a running title of no more than 60 characters, including spaces.
• Author List and Affiliations: Authors’ full first and last names must be provided along with complete address information including city, zip code, state/province, and country. Name and contact information of the corresponding author including current physical address, telephone, fax, and email address must also be provided. Only one author should be designated as the corresponding author; if more than one corresponding author is provided, only the first one listed will be contacted.
• Abstract: The abstract should be a single paragraph and an objective representation of the article. The abstract should not exceed 250 words. The main results should be highlighted. No references should be included in the abstract
• Keywords: Four to six keywords should be presented after the abstract. Keywords should be specific to the article, yet common within the subject discipline.
• Highlights: All manuscript must include 3 highlights that capture the novel results of the research as well as new methods used during the study. Each highlight should not exceed 85 characters including spaces.

Main Text

• Introduction: The introduction should be a brief summary of relevant background information required to justify the study rationale. Authors should avoid providing an excessive literature review or detailed summary of the current study results. The final paragraph should contain a clear statement of the study aims/hypothesis, brief description of the study design, and potential implications to the greater research field.
• Materials and Methods: The materials and methods section should provide a sufficient detail to allow for replication. New methods should be described in detail while well-established methods should be cited. Provide the name and version of any software used and any pre-registration codes. All primary antibodies used must have their catalog number mentioned. The suppliers along with the city and country must also be provided. The materials and methods section should end with a detailed descriptions of the statistical analysis methods used; the exact p value must be provided, for example p = 0.03 rather than p < 0.05. The materials and methods section should also contain all ethical statements and approval numbers, inform consent statement, and, when appropriate, clinical trial registration (clinical trial must be registered at Clinicaltrials.gov). When reporting on research that involves human subjects, human material, human tissues, or human data, authors must declare that the investigations were carried out following the rules of the Declaration of Helsinki of 1975 (https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/), revised in 2013. In cases where ethical approval is not required or inform consent is waved, authors must provide explanation. Methods of euthanasia, or chemicals used in anesthesia, must also be stated when dealing with animal studies along with the following statement:“All efforts were made to minimize the number of experimental animals and their suffering.” Methods sections for submissions reporting on research with cell lines should state the origin of any cell lines. For established cell lines the provenance should be stated, and references must also be given to either a published paper or to a commercial source. If previously unpublished de novo cell lines were used, including those gifted from another laboratory, details of institutional review board or ethics committee approval must be given, and confirmation of written informed consent must be provided if the line is of human origin. Plants studies (either cultivated or wild) including collection of plant material, must comply with institutional, national, or international guidelines.
• Results: Provide a concise and precise description of the experimental results; figures and tables, along with the corresponding legends, are to be placed in the text immediately following their first mention. To prevent delays in publication, ensure that the figures’ quality is of high standard and clarity.
• Discussion: The discussion should include an introductory paragraph that highlights the key findings. Each subsequent paragraph should interpret the key results in turn within the context of other previously published studies that either support or refute the current study findings. Do not provide extended background or simply restate the results without interpretation. The discussion must also include a separate paragraph highlighting the limitations of the study. Subsections may be included if applicable.
• Conclusions: Do not include background information or study limitations. Possible future directions should be included as well as a clear statement regarding the application or translational significance of the findings to the research field.
• Funding: All sources of funding of the study should be disclosed. Grant numbers must also be provided
• Acknowledgments: Provide any acknowledgments of those who contributed to the study or manuscript, however, do not meet the requirement for authorship. Funding information must not be included in this section.
• Author Contributions: The contributions of each author must be listed.
• Data Availability Statement: Original articles must provide a statement of data availability to ensure transparency.
• Conflicts of Interest: Authors must list all potential conflicts of interest or indicate “The authors declare no conflicts of interest.”
• References: References must be numbered in order of appearance. In the text, reference numbers should be placed in square brackets, [ ], placed before the punctuation; for example [1], [1–3], or [1,3].
  References should be listed at the end of the manuscript. List only 3 authors; should there be more than 3 authors, list only the first 3 followed by et al.

• Journal Articles:
  Author AB, Author CD, Author EF. Title of the article. Abbreviated Journal Name Year, Volume, page range. doi:xxxxxxxx

  Example: Smith J, Wang Z, Ahmed M, et al. Cell and cell processing. Sci Rep 2022;1:12–14. doi:10.1016456548.

  Books and Book Chapters:
  Author A, Author B. Book Title, 3rd ed.; Publisher: Publisher Location, Country, Year; pp. x–y.
  Author A, Author B. Title of the chapter. In Book Title, 2nd ed.; Editor 1, A., Editor 2, B., Eds.; Publisher: Publisher Location, Country, Year;
  Volume, pp. x–y.

• Websites: Title of Site. Available online: URL (accessed on Day Month Year).

Click here to download a copy of the GGPGR Manuscript Template
Click here to download a copy of the GGPGR Supplementary Material Template

Additional data and files can be uploaded as “Supplementary Files.” Supplementary files should be submitted using the Supplementary File Word template.

Plagiarism includes copying text, ideas, images, or data from another source, even from one’s own previous publications, without giving any credit to the original source. All manuscript submitted to GGPGR will undergo plagiarism check. Manuscript with a score of ≥ 26 will be returned to the author without review for revision, therefore, authors are encouraged to conduct a plagiarism check prior to submission.

Authors must use the submission system to submit manuscript and supplementary information files. Manuscript submitted via email will not be considered or reviewed. The submission system is design to gather all necessary inflammation. Authors must sign in by creating an account to track the progress of, or decision on, their paper.

Upon submission, the Editorial Board will conduct the initial manuscript screening. Poorly written manuscripts will be returned to the authors for English language editing. Manuscript deemed appropriate will be sent for peer review.

During the submission process, authors must provide the name and contract information of 5 potential reviewers. The Editorial office will contact the reviewers for the manuscript peer review process and will check to make sure there are no conflicts of interest before contacting those reviewers and will not consider those with competing interests. Reviewers will be asked to declare any conflicts of interest.

GGPR follows a single-blind review process, where authors’ identities are known to reviewers. The reviewers will provide feedback on the manuscript and this feedback will be only shared with the manuscript’s authors (will be sent to the corresponding author).

Following peer review, manuscripts are categorized as follows:

• Accept with no change
• Accept after Minor Revisions
• Reconsider after Major Revisions
• Reject and Encourage Resubmission
• Reject

All reviewer comments should be responded to in a point-by-point fashion. Where the authors disagree with a reviewer, they must provide a clear response. Revisions in the manuscript must be highlighted. Authors are welcome to appeal journal decision and will be considered on case-by-case basis.

GGPGR charges flat, non-refundable, processing fees regardless of the number of Figures in the Manuscript or Supplementary File.
Submission fee: $50
Manuscript processing fee: $1200
Supplementary File processing fee: $300
Time from initial submission to first decision: 1 week
Peer review process: 2 weeks
Acceptance to publication: 1 week
*GGPGR is committed to rapid review and publication of manuscript upon acceptance; however, these times may slightly vary based on the manuscripts.